Compare
EBR Systems, Inc. vs Vycor Medical Inc vs PetVivo Holdings, Inc. vs Femasys Inc
| Latest fiscal year | EBR Systems, Inc. NONE. | Vycor Medical Inc VYCO | PetVivo Holdings, Inc. PETV | Femasys Inc FEMY |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | $1.62M | $1.86M | $1.14M | $2.29M |
| Revenue growth (YoY) | n/a | +17.2% | +0.8% | +40.8% |
| Gross margin | 30.3% | 83.8% | 66.1% | 62.0% (computed) |
| Operating margin | n/m | 1.8% | -793.9% | -767.0% |
| Net margin | n/m | -3.9% | -917.4% | -812.3% |
| Net income | -$48.76M | -$72.4K | -$10.47M | -$18.63M |
| EPS (Diluted) | -$0.12 | -$0.01 | -$0.38 | -$0.47 |
| Operating cash flow | -$53.19M | -$13.5K | -$6.11M | -$18.69M |
| Free cash flow | -$56.88M | -$18.7K | -$6.12M | -$19.22M |
| Cash & equivalents | $5.79M | $87.0K | n/a | $9.27M |
| Total assets | $97.23M | $830.4K | $3.58M | $20.72M |
| Total liabilities | $71.64M | $4.92M | $1.38M | $14.85M |
| Shareholders' equity | $25.59M | -$4.09M | $2.20M | $5.87M |
| Return on year-end equity | -190.6% | n/a | -476.2% | -317.4% |
| Shares outstanding | 450.26M | 33.37M | 35.85M | 59.60M |
Revenue, most recent five fiscal years
| Fiscal year | EBR Systems, Inc. | Vycor Medical Inc | PetVivo Holdings, Inc. | Femasys Inc |
|---|---|---|---|---|
| Latest | $1.62M Ended 2025-12-31 | $1.86M Ended 2025-12-31 | $1.14M Ended 2026-03-31 | $2.29M Ended 2025-12-31 |
| 1 year earlier | n/a | $1.59M Ended 2024-12-31 | $1.13M Ended 2025-03-31 | $1.63M Ended 2024-12-31 |
| 2 years earlier | n/a | $1.46M Ended 2023-12-31 | $968.7K Ended 2024-03-31 | $1.07M Ended 2023-12-31 |
| 3 years earlier | n/a | $1.22M Ended 2022-12-31 | $917.2K Ended 2023-03-31 | $1.21M Ended 2022-12-31 |
| 4 years earlier | n/a | $1.39M Ended 2021-12-31 | $115.6K Ended 2022-03-31 | $1.18M Ended 2021-12-31 |